Short Call at News Buzzer: Alphabet Inc. (NASDAQ:GOOGL), FireEye, Inc. (NASDAQ:FEYE)

Alphabet Inc. (NASDAQ:GOOGL) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -0.26% to close at $776.18 with the total traded volume of 1.73 Million shares. Google released that Android 7.1.1 Nougat update for Nexus and Pixel devices, and the update has begun rolling out across the world. A Gadgets 360 staff member received the update on his Pixel XL smartphone, and learnt that the smartphone now supports 4G VoLTE, compatible with Reliance Jio in India.To use 4G VoLTE, Google Pixel and Pixel XL users will need to enable Enhanced 4G LTE Mode in Settings > Mobile network settings.

This will let you “use LTE services to improve voice and other communications”. Once activated, users will see a HD symbol in their status bar, with the explanation “Device is HD capable”.The Android 7.1.1 Nougat update for Google Pixel XL is 263.6MB in size, and also brings the December Android Security Patch. If you haven’t yet received the update, and can’t wait to try out the VoLTE feature, you can upgrade to the latest version via the OTA files on Google’s site. The firm has institutional ownership of 81.10%, while insider ownership included 0.10%. Its price to sales ratio ended at 6.19. GOOGL attains analyst recommendation of 1.80 with week performance of -1.68%.

FireEye, Inc. (NASDAQ:FEYE) [Trend Analysis] surged reacts as active mover, shares an advance 1.54% to traded at $13.20 and the percentage gap between open changing to regular change was -0.31%. The intelligence-led security company, FireEye, Inc. (NASDAQ: FEYE) released that participation in the Barclays Global Technology, Media and Telecommunications conference in San Francisco. The presentation is planned for 4 p.m. PST Wednesday, December 7, 2016 and will be webcast. Links to the live and archived webcasts will be accessible from the investor relations section of the company’s website The firm’s current ratio calculated as 2 for the most recent quarter. The firm past twelve months price to sales ratio was 3.12 and price to cash ratio remained 2.40. As far as the returns are concern, the return on equity was recorded as -57.90% and return on investment was -29.20% while its return on asset stayed at -22.80%. The firm has total debt to equity ratio measured as 0.85.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *